Pacific Biosciences Of California | PACB - 资产



金融业
股票价格
USD
资产
USD 751.85M
现金及等价物
USD 61M
销售成本
USD 28.9M
流动资产
USD 338.64M
流动负债
USD 68.81M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD -33.21M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 306.8M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 61.08M
贸易债权人
USD 19.22M
应收帐款人
USD 35.45M


资产 更改 日
Agilent USD 13.07B 252M 2026-03
Bruker USD 6.05B 77.8M 2026-06
Danaher USD 92.37B 8.82B 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Illumina USD 6.65B 91M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Pacific Biosciences Of California USD 751.85M 30.51M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Waters USD 24.75B 220M 2026-06